Navigation Links
SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193

s to market these or other potential products, (c) SIGA may not be able to obtain anticipated funding for its development projects or other needed funding, (d) SIGA may not be able to secure funding from anticipated government contracts and grants, (e) SIGA may not be able to secure or enforce adequate legal protection, including patent protection for its products, and (f) regulatory approval for SIGA's products may require further or additional testing that will delay or prevent approval. More detailed information about SIGA and risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this Press Release, are set forth in SIGA's filings with the Securities and Exchange Commission, including SIGA's Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and in other documents that SIGA has filed with the Commission. SIGA urges investors and security holders to read those documents free of charge at the Commission's Web site at http://www.sec.gov. Interested parties may also obtain those documents free of charge from SIGA. Forward-looking statements speak only as to the date they are made, and, except for any obligation under the U.S. federal securities laws, SIGA undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.

Contact

SIGA Technologies, Inc.
Dr. Eric A. Rose, 212-672-9100
Chairman and Chief Executive Officer
info@siga.com
or
Cameron Associates
Al Palombo, 212-245-8800 Ext. 209
Investor Relations
al@cameronassoc.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
5. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
6. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
7. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
10. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
11. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: SIGA Passes First Hurdle with Lassa Fever Antiviral
(Date:12/24/2014)... 24, 2014  Conkwest, Inc., the Natural Killer ... Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as ... Soon-Shiong , NantWorks founder, physician scientist and biotechnology ... purchase approximately $48 million of the Company,s Class ... he will be named Co-Chairman of the Conkwest ...
(Date:12/24/2014)... and LONDON , December 24, ... industry are expected to grow at an average rate ... of value and volume. Hip, knee and spine surgeries ... while in emerging economies they have a lower penetration. ... challenging the use of composites. Non-metallic orthopedic devices have ...
(Date:12/24/2014)... Dec. 23, 2014  Advanced Medical Isotope Corporation ... primarily in the development of brachytherapy devices and ... announced that it has filed a de ... Administration ("FDA") for marketing clearance for its patented ... the U.S. Food, Drug and Cosmetic Act (the ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... 2011 SurgiCount Medical, Inc., the wholly-owned operating subsidiary ... today announced that it has signed an agreement, effective ... in one of the largest hospital operators in the ... a minimum number of hospitals, SurgiCount and the operator ...
... HeartWare International, Inc. (NASDAQ: HTWR ; ASX: ... support technologies that are revolutionizing the treatment of advanced ... HeartWare® Ventricular Assist System will be presented on Sunday, ... in Lisbon, Portugal. A presentation by Mark ...
Cached Medicine Technology:SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System 2SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System 3HeartWare Announces Presentation of Clinical Data at the 25th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Lisbon 2
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... sick children with complex chronic illnesses can receive effective, less ... home," with easy access to a team of dedicated health ... likely to become seriously ill and need either hospitalization or ... at an enhanced medical home clinic at the University of ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- Overeating is common during ... eat in moderation, an expert says. "Don,t arrive at ... calories if you know you,ll be attending a party, but ... Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount Kisco, ... to eat healthy during the day and even to have ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... a "fountain of youth" drug that can delay the effects ... new study suggests. Seniors received a significant boost to ... genetic signaling pathway linked to aging and immune function, researchers ... experimental medication, a version of the drug rapamycin, improved the ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Plugin creators ... ProFire 5k. A fully customizable business presentation tool made ... “Adding the ProFire 5k business tool, users can now ... Austin, CEO of Pixel Film Studios. “ProFire 5k gives ... style to add professionalism to a presentation” , Pixel ...
Breaking Medicine News(10 mins):Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... ... testing and certification program by adding two new testing categories and expanding the existing extractors ... Stain Category, a Platinum Level for Extractors and Systems, and an Energy Efficiency Rating Option ... (PRWEB) February ...
... , , , Donations Help ... Pa. , Feb. 15 The Pennsylvania Breast Cancer ... Cervical Research campaign to fund PA researchers. By simply checking YES ... can donate all or part of their state income tax refund ...
... use, study indicates , MONDAY, Feb. 15 (HealthDay News) ... include Avandia and Actos, are at a greater risk of ... a thiazolidinedione drug for a year were 50 percent more ... take the drug, the researchers found. Women older than 65 ...
... , THE WOODLANDS, Texas ... nation,s premier oncology services company supporting the nation,s largest network including more ... advance cancer care in America, was honored on Feb. 6 , ... the Nation All-Star Football Challenge in El Paso, Texas . ...
... ... networks to expand from three to four networks offering multi-channel interactive message deliver, ... ... provider of next-generation coast-to-coast co-location and disaster-recovery services, will facilitate the network expansion ...
... Facelift ... Jersey, is becoming more popular than ever in the battle to slow the progression of ... Cosmetic? , ... (PRWEB) February 15, 2010 – Facelift surgery is the second most popular cosmetic ...
Cached Medicine News:Health News:Carpet and Rug Institute Expands Seal of Approval Program 2Health News:Carpet and Rug Institute Expands Seal of Approval Program 3Health News:PA Breast Cancer Coalition Launches Income Tax Refund Campaign 2Health News:Diabetes Drugs Avandia, Actos Tied to Fractures in Women 2Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 2Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 3Health News:MarquisNet Co-Location Agreement with MessageBroadcast Helps Message Delivery Provider Expand World-Class Network 2Health News:MarquisNet Co-Location Agreement with MessageBroadcast Helps Message Delivery Provider Expand World-Class Network 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 2Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 4
... corrected IOP measurements in the palm of your ... Make your IOP readings more meaningful with ... built-in IOP calculations. The IOPac is ... accurate corneal measurements in a portable platform and ...
Use the Oculus Mesotest II before and after IOL or refractive surgery. Selectable Landolt ring positions. Accurate measurements in four contrast levels, with and without glare, independent of the pup...
... Hightech American Industrial Laboratories, Inc. specializes ... clinical, eyebank and laboratory specular microscopes, ... Fundus camera digital upgrade package. Our ... and image data correlation with rapid ...
... VersaSuite practice management software is ... the business and clinical aspects of ... solution offers support for the financial, ... the eye care professional. Designed as ...
Medicine Products: